View Clinical Trial (Medical Research Study)
Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. - NCT01128582-85723(Clinical Trial 650932)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Tucson |
|
State:
|
|
AZ |
| Zip Code: |
|
85723 |
| Conditions: |
|
Gastroesophageal Reflux Disease - Chronic Insomnia |
| Purpose: |
|
To determine if administration of Rozerem in comparison to a placebo reduces or eliminates
gastroesophageal reflux disease(GERD) symptoms in individuals with both GERD and chronic
insomnia.
|
| Study summary: |
|
This is a prospective, randomized, double-blind parallel group study comparing the effect of
Rozerem vs. placebo on gastroesophageal reflux disease(GERD) symptomatology as the primary
outcome, and sleep quality and quality of life as secondary outcomes. |
| Criteria: |
|
Inclusion Criteria:
- Stop H2 blockers 72 hrs prior to starting study
- Stop PPI - 3 weeks prior to staring study
- Heartburn 3+ times a week
- Insomnia 3+ times a week for 3 months
- Erosive esophagitis or Abnormal pH test
Exclusion Criteria:
- On PPI or H2 blocker & not willing to get off
- Normal EGD (upper endoscopy) w/ normal pH test
- Upper Endoscopy(EGD)with erosive esophagitis(EE)- (LA C&D) LA=Los Angeles criteria.
Grades include A-D
- Previous gastrointestinal Surgery
- HX of Diabetes/neuropathy
- HX of seizures
- Known psychological abnormalities(depression,anxiety...)
- Clinically Significant Underlying co morbidity
- Narcotic medications(pain meds)
- Regularly taking sleeping medications (2 week wash-out allowed)
- Taking medications that alter sleep-Psychotropic's, antihistamines, Narcotics and
Benzodiazepines Sleep Apnea or other sleep disorders-PLM, RLS etc. |
|
|
|
| Study is available at: |
|
Southern Arizona Veterans Health Care System Tucson, AZ 85723 United States
Primary Contact: Ronnnie Fass, MD Email: ronnie.fass@va.gov Phone: 520-792-1450
Secondary Contact: Ronnie FASS, MD Email: ronnie.fass@va.gov Phone: 520-792-1450 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|